RT-PCR
Overview
Reverse transcription polymerase chain reaction (RT-PCR) is the reference standard molecular method for dengue diagnosis during the acute viraemic phase. It detects dengue virus (DENV) RNA in serum, plasma, or whole blood, can identify the infecting serotype, and is highly sensitive during the first 5 days of illness. Quantitative real-time RT-PCR (qRT-PCR) additionally allows viraemia quantification and is used in research settings to define asymptomatic dengue by virological confirmation.
Key Points from Literature
Diagnostic performance and timing
- Detection window: DENV RNA is detectable from approximately 24–48 hours before fever onset through days 5–6 of illness (see Guzman2016 - Dengue Infection)
- Most sensitive during the first 5 days of illness; sensitivity declines sharply as viraemia clears
- After day 5–6, IgM-IgG Serology ELISA becomes the diagnostic method of choice; serological and molecular testing are complementary
- RT-PCR should not be used as the sole test when illness onset is >5 days ago; a negative result in that window cannot exclude dengue
Serotyping
- RT-PCR can identify the infecting DENV serotype (DENV-1, -2, -3, or -4) — critical for epidemiological surveillance and for interpreting secondary infection risk
- Serotype identification by conventional or multiplex RT-PCR is standard practice in reference laboratories
- Sequencing of RT-PCR amplicons allows genotype identification (e.g., distinguishing Asian from American DENV-2 genotype)
Quantitative RT-PCR (qRT-PCR)
- Allows measurement of viraemia titre; useful in research to assess correlates of disease severity
- Used as the definitional criterion for asymptomatic dengue infection in the Sungnak2025 Thailand cohort — positive DENV-specific qRT-PCR in individuals with no clinical symptoms (see Asymptomatic Dengue Infection)
- Viraemia levels correlate with disease severity particularly in secondary infection
Placement in WHO diagnostic tiered structure
- Reference laboratory level: RT-PCR and virus isolation (plaque assay, C6/36 cell culture)
- Intermediate level: NS1 ELISA, IgM ELISA (less resource-intensive than RT-PCR)
- Field level: rapid diagnostic tests (NS1 RDTs, combined NS1/IgM/IgG RDTs)
- This tiered structure reflects the resource requirements of RT-PCR: thermocycler, RNA extraction, molecular reagents, and trained staff
Comparison with other acute-phase tests
| Method | Start day | End day | Advantages | Disadvantages |
|---|---|---|---|---|
| RT-PCR | −2 (pre-fever) | ~5–6 | Highest sensitivity early; serotyping | Resource-intensive; reference lab required |
| NS1 antigen | ~1 | ~5–9 | Point-of-care formats available | Variable sensitivity by serotype/timing |
| Virus isolation | ~1 | ~5 | Gold standard virological confirmation | Slow (7–10 days); BSL-2 required |
| IgM ELISA | ~5–6 | Weeks | Widely available; point-of-care formats | Misses first 5 days; Zika cross-reactivity |
Contradictions & Debates
- Sensitivity of RT-PCR in primary vs secondary infection: secondary infection may have shorter or lower viraemia, potentially reducing sensitivity in some cases
- Zika virus RNA is co-detected by some dengue RT-PCR assays designed before 2015 (related flavivirus); dual testing now recommended where Zika circulates
Related Pages
- NS1 Antigen Detection
- IgM-IgG Serology ELISA
- Viraemia
- Dengue Clinical Classification
- Asymptomatic Dengue Infection
- qRT-PCR
- PRNT
Sources
- Guzman2016 - Dengue Infection
- Seet2007 - Post-Infectious Fatigue Syndrome in Dengue (reverse transcriptase-nested PCR, Lanciotti et al. 1992 protocol; used in subset [27/127 patients] for DENV serotyping in Singapore 2005 outbreak)
- Lin2001 - IgM Anti-Platelet Autoantibody in Dengue Patients (RT-PCR used to confirm DENV-3 in select patients [Patients 2 and 7] from the 1998–99 southern Taiwan outbreak; Taiwan CDC outbreak typing)
- Saito2004 - PAIgG and PAIgM in Secondary Dengue (Morita et al. 1991 protocol for dengue serotyping; additionally used to detect DENV RNA directly in purified platelet samples — positive in 42.8% of tested secondary-infection patients, supporting dengue virus localisation on circulating platelets)
- Vo2020 - Autoantibody Profiling in Dengue (RT-qPCR for virological confirmation of DENV infection in all patients; serotype identification by serotype-specific RT-qPCR; DENV-1 dominant in Cambodia 2012–2013 cohort; viral load quantification in copies/mL; also used to confirm asymptomatic DENV infection in household cluster investigation)
- Rajadhyaksha2012 - Dengue Evolving into SLE and Lupus Nephritis (DENV-1 genotype 1 confirmed by RT-PCR from acute-phase serum; Mumbai India; n=1 case report)
- Cheng2015 - NS1 P311-330 Anti-PDI Autoantibodies in DHF (one-step SYBR Green I real-time RT-PCR [Qiagen QuantiTect kit] for DENV serotype differentiation in acute-phase samples from Vietnamese DHF/DF paediatric cohort)
- Santosa2012 - Delayed SLE Diagnosis Dengue Serology (RT-PCR recommended as reliable confirmatory test within 5 days of fever in patients with autoantibodies — non-immunological RNA detection is unaffected by cross-reactive IgM autoantibodies that can cause false-positive dengue IgM serology; Singapore NUHS case report and algorithm)
- Farias2024 - Dengue Mimickers (RT-PCR recommended alongside NS1 antigen as preferred confirmatory test when dengue-vs-SLE/RA bidirectional confusion suspected; unaffected by autoantibody false-positive effect on IgM serology; Brazil narrative review — secondary source)
- Hung2008 - Anti-Platelet Anti-Endothelial Autoantibodies Vietnam (virus isolation followed by RT-PCR used for DENV serotype confirmation in children cohort; identified co-circulation of DENV-2, DENV-3, DENV-4 in HCMC Vietnam 1998–2002)
- Ghorai2024 - Autoantibodies in Dengue Pathogenesis Review (RT-PCR cited as method used in primary sources reviewed; Kolkata India; narrative review — secondary source)